Geode Capital Management, LLC Aslan Pharmaceuticals LTD Transaction History

Geode Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.11 - $1.86 $157,417 - $263,781	-141,818 Reduced 78.07%	39,841 $44,000
Q3 2021 Nov 12, 2021	BUY	$1.78 - $3.41 $83,017 - $159,038	46,639 Added 34.54%	181,659 $323,000
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.72 $284,960 - $424,020	113,984 Added 541.85%	135,020 $445,000
Q1 2021 May 12, 2021	BUY	$1.86 - $5.25 $39,126 - $110,439	21,036 New	21,036 $70,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.